REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/08/2025
Back to search
Official data from USPTO
CINGULATE THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CINGULATE THERAPEUTICS
ST13
US500000087878041Class
42
Filing
87878041
Registration
6144564
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
09/09/2025
Trademark type
Word
Nice classes
42
Filing date
04/16/2018
Registration date
09/08/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/08/2020
Last transaction
09/09/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/01/2014
First use in commerce
06/01/2014
Drawing code
4
Owner type
16
Owner location
Kansas City, KS
Examiner
AVENT, TEAGUE
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cingulate Therapeutics LLC
Representatives
Susan Neuberger Weller MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development services in the field of pharmaceuticals for the treatment of attention deficit/hyperactivity disorder (ADHD); conducting clinical trials for others in the field of pharmaceuticals for the treatment of attention- deficit/hyperactivity disorder (ADHD)
Publications
History of USPTO decisions and trademark events.
24 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/20/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/20/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/20/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/23/2020
PUBO
PUBLISHED FOR OPPOSITION
06/23/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/21/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/12/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
08/21/2019
ALIE
ASSIGNED TO LIE
08/08/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/07/2019
GNSL
LETTER OF SUSPENSION E-MAILED
01/07/2019
CNSL
SUSPENSION LETTER WRITTEN
01/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/14/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/13/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/13/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/13/2018
GNRT
NON-FINAL ACTION E-MAILED
08/13/2018
CNRT
NON-FINAL ACTION WRITTEN
08/13/2018
DOCK
ASSIGNED TO EXAMINER
08/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/23/2018
NWAP
NEW APPLICATION ENTERED
04/19/2018
Continuous trademark protection
Get notified about every new filing that threatens CINGULATE THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.